Search Results - Michael Method
- Showing 1 - 1 results of 1
-
1
Exposure–response relationships of mirvetuximab soravtansine in patients with folate receptor‐α‐positive ovarian cancer: Justification of therapeutic dose regimen by Ya‐Ping Tu, H. Maxime Lagraauw, Michael Method, Yuemei Wang, Eva Hanze, Lingling Li, Timothy Parrott, Callum M. Sloss, Eric H. Westin
Published 2024Get full text
Artículo Open Access